Skip to content Skip to footer
News

Potential new treatment pathway for bladder cancer

21 August 2024
A man in a lab coat and glasses
Associate Professor Fernando Guimaraes. Image: TRI

Key points

  • UQ researchers found that bladder cancer releases a protein called TGF-β to suppress the immune system’s natural killer (NK) cells
  • NK cells are components of the immune system that naturally attack cancer cells and are a focus of emerging cancer treatments
  • locking the TGF-β protein may offer a new therapy for some of the worst types of the cancer

University of Queensland research could lead to a more effective immunotherapy treatment against bladder cancer.

A team led by Associate Professor Fernando Guimaraes from UQ’s Frazer Institute has found the mechanism used by bladder cancer to suppress the immune system’s natural killer (NK) cells.

“We found that cancer suppresses immune cells by releasing a protein called TGF-β – and blocking that protein may offer a new therapy for some of the worst types of the cancer,” Dr Guimaraes said.

“NK cells are components of the immune system that naturally attack cancer cells and are a focus of emerging cancer treatments, including antibody-based immunotherapies.

“Our research is also a step towards clinical trials to explore the effectiveness of TGF-β inhibitors combined with NK cell-based therapies.

“Our work is all about unlocking the power of immunotherapy and our hope is that this leads to new bladder cancer therapies within 3 to 5 years.”

Bladder cancer is the ninth most common malignancy in the world – in 2023 more than 3000 people were diagnosed in Australia, with more than 1000 deaths.  

The bladder cancer immune suppression mechanism was discovered by Dr Guimaraes’ PhD candidate Joshua Wong while working at Queensland’s Translational Research Institute (TRI).

“It really was a eureka moment and it’s extremely motivating to come in here every day and do your best work, because ultimately we are trying to find a cure for cancer,” Mr Wong said.

Decorative

The standard treatment for early-stage bladder cancer remains endoscopic surgery, occasionally combined with chemotherapy or immunotherapy.

For advanced forms of the disease, more invasive surgery or radiotherapy is combined with chemotherapy or immunotherapy, which is associated with significant ill health and life-long impacts on quality of life.

The UQ team collaborated with Princess Alexandra Hospital urologists including Dr Handoo Rhee, Professor Eric Chung and Dr Alice Nicol.

The research was published in The Lancet’s eBioMedicine.

 

Related articles

An older person wearing a light blue cardigan sits at a dining table during a shared meal, facing another seated person in the foreground. A plate of food, a cup, glasses of water and a jug of orange juice are on the table, while a third person stands in a bright kitchen area in the background. The image conveys a social mealtime setting in a home-like environment.
Analysis

From cooked breakfast to their own TV, aged care residents need to watch for extra fees

Two residents in the same aged care facility can wake up to a very different day, depending on their budget and whether they and their families can afford to pay the new “Higher Everyday Living Fees” (HELF).
19 November 2026
Students walk in the sunshine outside the Forgan Smith Building

UQ rises 22 places in 2027 QS Sustainability Rankings

The University of Queensland (UQ) has risen 22 places to rank 28th globally in the QS Sustainability Rankings.
19 November 2026

Media contact

Subscribe to UQ News

Get the latest from our newsroom.